|
Jun 30
|
Are Investors Undervaluing Catalyst Pharmaceuticals (CPRX) Right Now?
|
|
Jun 23
|
CPRX vs. NBIX: Which Stock Is the Better Value Option?
|
|
Jun 19
|
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
|
|
Jun 18
|
Catalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings Growth
|
|
Jun 18
|
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock
|
|
Jun 10
|
Catalyst Pharmaceuticals, Inc. (CPRX) Hits Fresh High: Is There Still Room to Run?
|
|
Jun 6
|
Kymera Therapeutics Stock Earns 92 RS Rating
|
|
Jun 6
|
Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue?
|
|
Jun 6
|
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
|
|
Jun 4
|
What Makes Catalyst Pharmaceutical (CPRX) a Strong Momentum Stock: Buy Now?
|
|
Jun 4
|
If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now
|
|
Jun 3
|
Catalyst Pharmaceuticals (NasdaqCM:CPRX) Appoints Dr. William Andrews As New Chief Medical Officer
|
|
Jun 3
|
CPRX or NBIX: Which Is the Better Value Stock Right Now?
|
|
Jun 3
|
Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term
|
|
Jun 2
|
Does Catalyst (CPRX) Have the Potential to Rally 36.22% as Wall Street Analysts Expect?
|
|
Jun 2
|
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?
|
|
Jun 2
|
Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term
|
|
Jun 2
|
Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
|
|
May 14
|
The Strong Earnings Posted By Catalyst Pharmaceuticals (NASDAQ:CPRX) Are A Good Indication Of The Strength Of The Business
|
|
May 1
|
Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know
|